72 related articles for article (PubMed ID: 18045732)
1. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning.
Fritz P; Kraus HJ; Blaschke T; Mühlnickel W; Strauch K; Engel-Riedel W; Chemaissani A; Stoelben E
Lung Cancer; 2008 May; 60(2):193-9. PubMed ID: 18045732
[TBL] [Abstract][Full Text] [Related]
2. Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer.
Ueki N; Matsuo Y; Shibuya K; Nakamura M; Narabayashi M; Sakanaka K; Norihisa Y; Mizowaki T; Hiraoka M
J Radiat Res; 2013 Mar; 54(2):337-43. PubMed ID: 22984280
[TBL] [Abstract][Full Text] [Related]
3. Impact of dose to lung outside the planning target volume on distant metastasis or progression after SBRT for early-stage non-small cell lung cancer.
Hughes RT; Steber CR; Jacobson TJ; Farris MK
Radiother Oncol; 2021 Jun; 159():28-32. PubMed ID: 33711410
[TBL] [Abstract][Full Text] [Related]
4. SBRT Dose and Survival in Non-Small Cell Lung Cancer: In Regard to Koshy et al.
Levy A; Guckenberger M; Hurkmans C; Nestle U; Belderbos J; De Ruysscher D; Faivre-Finn C; Le Péchoux C
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):945-6. PubMed ID: 26104945
[No Abstract] [Full Text] [Related]
5. Perfusion-Limited Hypoxia Determines the Outcome of Radiation Therapy of Hypoxic Tumours.
Schiavo F; Toma-Dasu I; Lindblom EK
Adv Exp Med Biol; 2022; 1395():249-254. PubMed ID: 36527645
[TBL] [Abstract][Full Text] [Related]
6. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis.
Zhang R; Kang J; Ren S; Xing L; Xu Y
Ann Transl Med; 2022 Jan; 10(2):104. PubMed ID: 35282118
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy (SBRT) for T2N0 (>3 cm) non-small cell lung cancer: Outcomes and failure patterns.
Shamp SJ; Sheikh S; Chang T; Damico N; Linden P; Dowlati A; Machtay M; Biswas T
J Radiosurg SBRT; 2021; 7(4):271-277. PubMed ID: 34631228
[TBL] [Abstract][Full Text] [Related]
8. Chest wall toxicity after stereotactic radiation in early lung cancer: a systematic review.
Voruganti IS; Donovan E; Walker-Dilks C; Swaminath A
Curr Oncol; 2020 Aug; 27(4):179-189. PubMed ID: 32905234
[TBL] [Abstract][Full Text] [Related]
9. Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors.
Nicosia L; Reverberi C; Agolli L; Marinelli L; De Sanctis V; Valeriani M; Osti MF
Sci Rep; 2019 Oct; 9(1):15498. PubMed ID: 31664125
[TBL] [Abstract][Full Text] [Related]
10. Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
Lee P; Loo BW; Biswas T; Ding GX; El Naqa IM; Jackson A; Kong FM; LaCouture T; Miften M; Solberg T; Tome WA; Tai A; Yorke E; Li XA
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):160-171. PubMed ID: 30954520
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Chest Wall Toxicity During Long-term Follow Up After Thoracic Stereotactic Body Radiation Therapy.
Chipko C; Ojwang J; Gharai LR; Deng X; Mukhopadhyay N; Weiss E
Pract Radiat Oncol; 2019 May; 9(3):e338-e346. PubMed ID: 30731275
[TBL] [Abstract][Full Text] [Related]
12. Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes.
Hallemeier CL; Stauder MC; Miller RC; Garces YI; Foote RL; Sarkaria JN; Bauer HJ; Mayo CS; Olivier KR
J Radiosurg SBRT; 2013; 2(3):225-233. PubMed ID: 29296365
[TBL] [Abstract][Full Text] [Related]
13. Lung segmentectomy: does it offer a real functional benefit over lobectomy?
Charloux A; Quoix E
Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070582
[TBL] [Abstract][Full Text] [Related]
14. Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.
Chi A; Chen H; Wen S; Yan H; Liao Z
Radiother Oncol; 2017 Jun; 123(3):346-354. PubMed ID: 28545956
[TBL] [Abstract][Full Text] [Related]
15. Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models.
Liu F; Tai A; Lee P; Biswas T; Ding GX; El Naqa I; Grimm J; Jackson A; Kong FS; LaCouture T; Loo B; Miften M; Solberg T; Li XA
Radiother Oncol; 2017 Feb; 122(2):286-294. PubMed ID: 27871671
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
Bi N; Shedden K; Zheng X; Kong FS
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1378-1390. PubMed ID: 27479723
[TBL] [Abstract][Full Text] [Related]
17. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
19. Radiation pneumonitis after stereotactic radiation therapy for lung cancer.
Yamashita H; Takahashi W; Haga A; Nakagawa K
World J Radiol; 2014 Sep; 6(9):708-15. PubMed ID: 25276313
[TBL] [Abstract][Full Text] [Related]
20. Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability.
Lindblom E; Antonovic L; Dasu A; Lax I; Wersäll P; Toma-Dasu I
Radiat Oncol; 2014 Jun; 9():149. PubMed ID: 24974778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
